{"Title": "Genetic causes of PD: A pathway to disease modification", "Year": 2020, "Source": "Neuropharmacology", "Volume": "170", "Issue": null, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 8, "DOI": "10.1016/j.neuropharm.2020.108022", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85081698534&origin=inward", "Abstract": "\u00a9 2020 Elsevier LtdThe underline neuropathology of Parkinson disease is pleiomorphic and its genetic background diverse. Possibly because of this heterogeneity, no effective disease modifying therapy is available. In this paper we give an overview of the genetics of Parkinson disease and explain how this is relevant for the development of new therapies.", "AuthorKeywords": ["Disease modifying", "GBA1", "Genetics", "LRRK2", "Parkinson disease", "SNCA", "Therapy"], "IndexKeywords": null, "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-85081698534", "SubjectAreas": [["Pharmacology", "PHAR", "3004"], ["Cellular and Molecular Neuroscience", "NEUR", "2804"]], "AuthorData": {"57193903799": {"Name": "Toffoli M.", "AuthorID": "57193903799", "AffiliationID": "60022148, 60019953", "AffiliationName": "Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology"}, "57216058439": {"Name": "Vieira S.R.L.", "AuthorID": "57216058439", "AffiliationID": "60022148, 60019953", "AffiliationName": "Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology"}, "7102634392": {"Name": "Schapira A.H.V.", "AuthorID": "7102634392", "AffiliationID": "60022148, 60019953", "AffiliationName": "Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology"}}}